Literature DB >> 33779474

Outcomes of adult T-Cell leukemia/lymphoma with allogeneic stem cell transplantation: single-institution experience.

Zachary D Epstein-Peterson1, Nivetha Ganesan1, Juliet N Barker2,3, Pamela R Drullinsky1,3, Paola Ghione1, Ann A Jakubowski2,3, Anita Kumar1,3, Alison J Moskowitz1,3, Ariela Noy1,3, Miguel-Angel Perales2,3, Doris M Ponce2,3, Heiko Schoder3,4, James W Young2,3, Sergio A Giralt2,3, Steven M Horwitz1,3, Craig S Sauter2,3, Parastoo B Dahi2,3.   

Abstract

Few publications exist concerning allogeneic hematopoietic cell transplant (alloHCT) outcomes in non-Japanese patients with HTLV-1-associated ATLL. We detail the patient and disease characteristics, transplant approach, and clinical outcomes in 17 patients with ATLL at our institution who underwent alloHCT. We report favorable outcomes, with 8/17 in ongoing remission, 2/17 with prolonged (>6 years) disease-free survival, and a low incidence of transplant-related mortality (2/17). These results validate the feasibility and efficacy of alloHCT in non-Japanese patients with ATLL.

Entities:  

Keywords:  Adult T-cell leukemia lymphoma; allogeneic stem cell transplantation

Mesh：

Year:  2021        PMID： 33779474      PMCID： PMC9531547          DOI： 10.1080/10428194.2021.1897806

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


  17 in total

1.  Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study.

Authors:  Andrea Gallamini; Caterina Stelitano; Roberta Calvi; Monica Bellei; Daniele Mattei; Umberto Vitolo; Fortunato Morabito; Maurizio Martelli; Ercole Brusamolino; Emilio Iannitto; Francesco Zaja; Sergio Cortelazzo; Luigi Rigacci; Liliana Devizzi; Giuseppe Todeschini; Gino Santini; Maura Brugiatelli; Massimo Federico
Journal:  Blood       Date:  2003-11-26       Impact factor: 22.113

2.  Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.

Authors:  Mohamed L Sorror; Michael B Maris; Rainer Storb; Frederic Baron; Brenda M Sandmaier; David G Maloney; Barry Storer
Journal:  Blood       Date:  2005-06-30       Impact factor: 22.113

3.  Syngeneic hematopoietic stem cell transplantation from HTLV-1 seropositive twin for adult T-cell leukemia-lymphoma.

Authors:  Oscar B Lahoud; Alison J Moskowitz; Steven M Horwitz; Sergio A Giralt; Parastoo B Dahi
Journal:  Bone Marrow Transplant       Date:  2018-01-22       Impact factor: 5.483

4.  Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.

Authors:  Bruce D Cheson; Richard I Fisher; Sally F Barrington; Franco Cavalli; Lawrence H Schwartz; Emanuele Zucca; T Andrew Lister
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

5.  National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Authors:  Alexandra H Filipovich; Daniel Weisdorf; Steven Pavletic; Gerard Socie; John R Wingard; Stephanie J Lee; Paul Martin; Jason Chien; Donna Przepiorka; Daniel Couriel; Edward W Cowen; Patricia Dinndorf; Ann Farrell; Robert Hartzman; Jean Henslee-Downey; David Jacobsohn; George McDonald; Barbara Mittleman; J Douglas Rizzo; Michael Robinson; Mark Schubert; Kirk Schultz; Howard Shulman; Maria Turner; Georgia Vogelsang; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2005-12       Impact factor: 5.742

6.  A critical analysis of prognostic factors in North American patients with human T-cell lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma: a multicenter clinicopathologic experience and new prognostic score.

Authors:  Adrienne A Phillips; Iuliana Shapira; Robert D Willim; Jasotha Sanmugarajah; William B Solomon; Steven M Horwitz; David G Savage; Govind Bhagat; Gerald Soff; Jasmine M Zain; Bachir Alobeid; Venkatraman E Seshan; Owen A O'Connor
Journal:  Cancer       Date:  2010-07-15       Impact factor: 6.860

7.  Epidemiology, clinical features, and outcome of HTLV-1-related ATLL in an area of prevalence in the United States.

Authors:  Luis Malpica; Agustin Pimentel; Isildinha M Reis; Eduardo Gotuzzo; Lazaros Lekakis; Krishna Komanduri; Thomas Harrington; Glen N Barber; Juan C Ramos
Journal:  Blood Adv       Date:  2018-03-27

Review 8.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

9.  HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry.

Authors:  Loren Gragert; Mary Eapen; Eric Williams; John Freeman; Stephen Spellman; Robert Baitty; Robert Hartzman; J Douglas Rizzo; Mary Horowitz; Dennis Confer; Martin Maiers
Journal:  N Engl J Med       Date:  2014-07-24       Impact factor: 91.245

10.  Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting.

Authors:  Kunihiro Tsukasaki; Olivier Hermine; Ali Bazarbachi; Lee Ratner; Juan Carlos Ramos; William Harrington; Deirdre O'Mahony; John E Janik; Achiléa L Bittencourt; Graham P Taylor; Kazunari Yamaguchi; Atae Utsunomiya; Kensei Tobinai; Toshiki Watanabe
Journal:  J Clin Oncol       Date:  2008-12-08       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.